Skip to main content
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study.
Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy.
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant.
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.
Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.